Showing results (201-210 of 219) with videos related to

Sort By:
Pageof 22
Bone Marrow Transplantation|September 4, 2021
Impact of HLA disparity on the risk of overall mortality in patients with grade II-IV acute GVHD on behalf of the HLA Working Group of Japan Society for Hematopoietic Cell TransplantationShigeo Fuji, Akitoshi Hakoda, Junya Kanda, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 8, 2025
Prognostic Impact of Cytomegalovirus Reactivation After Transplantation From Cord Blood Compared to Other Donor Sources in Patients With Adult T-Cell Leukemia/Lymphoma in the Pre-Letermovir EraTakuya Fukushima, Hidehiro Itonaga, Hikaru Sakamoto, et al.
Blood Advances|January 26, 2021
Chromosomal defects and survival in patients with adult T-cell leukemia/lymphoma after allogeneic HSCTNobuaki Nakano, Atae Utsunomiya, Keitaro Matsuo, et al.
The Lancet Regional Health. Western Pacific|December 18, 2023
Outcomes in human T-cell leukemia virus type I carriers after hematopoietic stem cell transplantation for diseases other than adult T cell leukemia/lymphoma: a Japanese national surveyNobuaki Nakano, Hideki Nakasone, Shigeo Fuji, et al.
British Journal of Haematology|June 16, 2026
Improvements over time in survival after post-transplant relapse of adult T-cell leukaemia/lymphoma and trends of salvage therapy in a real-world experienceHidehiro Itonaga, Takuya Fukushima, Koji Kato, et al.
British Journal of Haematology|October 19, 2024
Comparative outcomes of various transplantation platforms, highlighting haploidentical transplants with post-transplantation cyclophosphamide for adult T-cell leukaemia/lymphomaMakoto Yoshimitsu, Takashi Tanaka, Nobuaki Nakano, et al.
Blood Advances|September 9, 2021
Improved survival of patients with aggressive ATL by increased use of allo-HCT: a prospective observational studyAyumu Ito, Nobuaki Nakano, Takashi Tanaka, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 12, 2022
Immunogenicity of three versus four doses of 13-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine in allogeneic haematopoietic stem cell transplantation recipients: a multicentre, randomized controlled trialKeiji Okinaka, Yukihiro Akeda, Yoshihiro Inamoto, et al.
Annals of Hematology|May 21, 2025
Impact of graft-versus-host disease on outcomes of cord blood transplantation according to HLA disparity and its prophylaxis typeHisayuki Yokoyama, Shigeo Fuji, Makoto Murata, et al.
Leukemia & Lymphoma|May 6, 2020
Pretreatment serum soluble interleukin-2 receptor level predicts survival in patients with newly diagnosed follicular lymphomaKenji Nozaki, Hiroyuki Sugahara, Shuji Ueda, et al.
Pageof 22